Abstract:Abstract Background Programmed cell death ligand 1 (PD-L1) is an immune checkpoint molecule that attenuates the immune response. PD-L1 contributes to failed antitumor immunity; thereby, blockade of PD-L1 with monoclonal antibody enhances the immune response. Recently, it was reported that PD-L1 was regulated by protein 53 (p53). Besides, cytokeratin 17 (CK17) is thought to be a diagnostic marker of oral squamous cell carcinoma (OSCC). Our aim was to evaluate the correlation between the immunohistochemical expression of PD-L1, p53 and CK17 with clinicopathological characteristics and disease-specific survival in patients with OSCC. Methods A total of 48 patients with OSCC were included in this study. Immunohistochemical staining was performed to evaluate the correlation among the expressions of PD-L1, p53 and CK17, and furthermore the correlation among various clinicopathological factors, PD-L1, p53 and CK17. Results The positive rate of p53, CK17, PD-L1 (tumor cells) and PD-L1 (tumor-infiltrating lymphocytes) was 63.2%, 91.7%, 48.9% and 57.1%. A statistically significant correlation between p53 expression and T stage and TNM stage ( p = 0.049, p = 0.03, respectively) was observed. Also, a statistically significant correlation between p53 and PD-L1 (TCs) expression ( p = 0.0009) was observed. Five-year disease-specific survival rate was not significantly correlated with gender, TNM stage, p53 expression, PD-L1 expression and CK17 expression. Conclusion The expression of p53 and PD-L1 shows significantly positive correlation in oral squamous cell carcinoma in tumor cells. Also, a significant correlation between p53 expression and T stage and TNM stage was observed. No other significant correlation between PD-L1 staining or CK17 and clinical or pathologic characteristics was identified.

[Expressions of PDCD5 and P53 in Oral Leukoplakia and Oral Squamous Cell Carcinoma].

Immunohistochemical Analysis of P57(kip2), P53 and Hsp60 Expressions in Premalignant and Malignant Oral Tissues

P57(Kip2) Expression is Related to Carcinogenesis and Tumor Progression in Laryngeal Tissues

Expressions of P53 and Nm23 Proteins in Oral Squamous Cell Carcinoma

Decreased Expression Of Bar Is Correlated With Poor Prognosis In Oral And Oropharyngeal Carcinoma

Immunohistochemical Detection of Aurora A and ERK Pathway in Oral Leukoplakia and Oral Squamous Cell Carcinoma

[Expression of Apoptosis-Related Protein in Epithelial Dysplasia and Squamous Cell Carcinoma].

Expression of MDR1mRNA detected and its correlation with p53 in esophageal carcinoma by in situ hybridization

The Expression of P16, P53 and Ki-67 Protein in Epithelial Dysplasia from Oral Mucosa and a Follow-Up Study of Four Years

[Expression of PDCD5 in Tissues of Normal Cervix, CIN I-III and Cervical Cancer].

The relationship between P53 over-expression and micronuclei in cancerous and precancerous lesion of oral mucosa

Expression of P16, P53 and Ki-67 Proteins in the Progression of Epithelial Dysplasia of the Oral Cavity.

Expressions of p53 and hMSH2 in colon carcinoma

[Expression and correlation of HPV16E6 and tumor suppressor gene p53 in oral squamous cell carcinoma]

PD-L1 expression correlated with p53 expression in oral squamous cell carcinoma

p53-positive expression in dysplastic surgical margins is a predictor of tumor recurrence in patients with early oral squamous cell carcinoma.

Expression of p53, p16 and COX-2 in pancreatic cancer with tissue microarray.

Analysis of CyclinD1,p27 and PTEN Proteins Expression in Oral Squamous Cell Carcinoma

Expression of P53, Mdm2, P21, Heat Shock Protein 70, and Hpv 16/18 E6 Proteins in Oral Verrucous Carcinoma and Oral Verrucous Hyperplasia

[Human Papillomavirus, Human Cytomegalovirus and P53 Gene in Cervical Carcinoma].

Immunohistochemical Analysis of Dendritic Cell in Oral Squamous Cell Carcinoma